文章简介

出版社:Journal of Hand Therapy

作   者:Brian T. Carlsen MD , Pat Prigge CP, FAAOP , Jennifer Peterson MA, PT

编   号:10.1016/j.jht.2013.10.007

年   份:2014    点击量:516

文章摘要

      For several decades, prosthetic use was the only option to restore function after upper extremity amputation. Recent years have seen advances in the field of prosthetics. Such advances include prosthetic design and function, activity-specific devices, improved aesthetics, and adjunctive surgical procedures to improve both form and function. Targeted reinnervation is one exciting advance that allows for more facile and more intuitive function with prosthetics following proximal amputation. Another remarkable advance that holds great promise in nearly all fields of medicine is the transplantation of composite tissue, such as hand and face transplantation. Hand transplantation holds promise as the ultimate restorative procedure that can provide form, function, and sensation. However, this procedure still comes with a substantial cost in terms of the rehabilitation and toxic immunosuppression and should be limited to carefully selected patients who have failed prosthetic reconstruction. Hand transplantation and prosthetic reconstruction should not be viewed as competing options. Rather, they are two treatment options with different risk/benefit profiles and different indications and, hence vastly different implications.

    几十年来,假肢是上肢截肢术后功能恢复的唯一选择。近年来,假肢领域已取得了新进展,包括假肢的设计及功能、特定活动设备、美观改进和辅助外科手术,用以提高假肢的外观和功能。定向神经再生是一个振奋人心的进步,它能够在近端截肢后获得更便捷、更直观的功能修复。另一个几乎在整个医学领域均大有前途的显著进步是复合组织移植,例如手部和脸部移植。手部移植最终有望恢复外观、功能和感觉。然而,该手术仍然要耗费巨大的成本进行康复和毒性免疫抑制,并应谨慎选择假肢重建失败的患者。手移植和假肢重建不应被视为竞争性方案。相反,他们是两种具有不同风险/利害关系、针对不同适应症的治疗方案,因此两者意义有很大不同。

 

 

Midcool医库软件 王露黔 编译

原文来自Journal of Hand Therapy